Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration.

[1]  B. Brenner,et al.  Glomerular permselectivity: barrier function based on discrimination of molecular size and charge. , 1978, The American journal of physiology.

[2]  B. Skoog.  Determination of Polyethylene Glycols 4000 and 6000 in Plasma Protein Preparations , 1979, Vox sanguinis.

[3]  R. L. Childs,et al.  The preparation and labeling of DTPA-coupled albumin. , 1982, The International journal of applied radiation and isotopes.

[4]  D. Lloyd,et al.  HBTU activation for automated Fmoc solid-phase peptide synthesis. , 1991, Peptide research.

[5]  M. Welch,et al.  Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  M. Hashida,et al.  Disposition characteristics of model macromolecules in the perfused rat kidney. , 1993, Biological & pharmaceutical bulletin.

[7]  M. Hashida,et al.  Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats. , 1999, Journal of pharmaceutical sciences.

[8]  H. Harashima,et al.  Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[9]  R. Juliano,et al.  Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers. , 2000, Nucleic acids research.

[10]  S. Kawakami,et al.  Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. , 2000, Biochimica et biophysica acta.

[11]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[12]  D. Tomalia,et al.  Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. , 2001, Drug discovery today.

[13]  Y. Tabata,et al.  Controlled Release of Hepatocyte Growth Factor from Gelatin Hydrogels Based on Hydrogel Degradation , 2001, Journal of drug targeting.

[14]  F. Szoka,et al.  Steric stabilization of fusogenic liposomes by a low-pH sensitive PEG--diortho ester--lipid conjugate. , 2001, Bioconjugate chemistry.

[15]  K. Ulbrich,et al.  New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[16]  R. Haag,et al.  Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. , 2002, Angewandte Chemie.

[17]  Takuro Niidome,et al.  In vitro gene transfection using dendritic poly(L-lysine). , 2002, Bioconjugate chemistry.

[18]  Robert J. Lee,et al.  A folate receptor-targeted emulsion formulation for paclitaxel. , 2003, Anticancer research.

[19]  Hisataka Kobayashi,et al.  Micro-magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic resonance imaging contrast agent. , 2003, Cancer research.

[20]  Vladimir P Torchilin,et al.  Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. , 2004, Advanced drug delivery reviews.

[21]  Y. Tabata,et al.  Suppression of the Progress of Disseminated Pancreatic Cancer Cells by NK4 Plasmid DNA Released from Cationized Gelatin Microspheres , 2004, Pharmaceutical Research.

[22]  Takuro Niidome,et al.  Characters of dendritic poly(L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro. , 2004, Biomaterials.

[23]  S. Davis,et al.  Design and Evaluation of an Emulsion Vehicle for Paclitaxel. I. Physicochemical Properties and Plasma Stability , 2004, Pharmaceutical Research.

[24]  T. Niidome,et al.  Long circulation of intravenously administered plasmid DNA delivered with dendritic poly(L-lysine) in the blood flow. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[25]  R. L. Juliano,et al.  PAMAM Dendrimers as Delivery Agents for Antisense Oligonucleotides , 2004, Pharmaceutical Research.

[26]  Jong-sang Park,et al.  Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[27]  M. Knopp,et al.  Polyamine dendrimer‐based MRI contrast agents for functional kidney imaging to diagnose acute renal failure , 2004, Journal of magnetic resonance imaging : JMRI.

[28]  M. Hashida,et al.  Macromolecular Carrier Systems for Targeted Drug Delivery: Pharmacokinetic Considerations on Biodistribution , 1996, Pharmaceutical Research.

[29]  F. Hirayama,et al.  Enhancing effects of galactosylated dendrimer/alpha-cyclodextrin conjugates on gene transfer efficiency. , 2005, Biological & pharmaceutical bulletin.

[30]  S. Kawakami,et al.  Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice , 2005, Journal of drug targeting.

[31]  R. Juliano,et al.  Tat-Conjugated PAMAM Dendrimers as Delivery Agents for Antisense and siRNA Oligonucleotides , 2005, Pharmaceutical Research.

[32]  M. Jan,et al.  Mechanism of cell death induced by cationic dendrimers in RAW 264.7 murine macrophage‐like cells , 2005, The Journal of pharmacy and pharmacology.

[33]  B. Hirst,et al.  Antibiotic exposure does not influence MRP2 functional expression in Caco-2 cells , 2005, Journal of drug targeting.

[34]  T. Okano,et al.  Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration. , 2005, Journal of pharmaceutical sciences.

[35]  K. Kataoka,et al.  Preparation of a novel PEG-clay hybrid as a DDS material: dispersion stability and sustained release profiles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[36]  T. Ishihara,et al.  Treatment of experimental arthritis with poly(d, l-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate , 2005, Annals of the rheumatic diseases.

[37]  Kazunori Kataoka,et al.  Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. , 2005, Bioconjugate chemistry.